Pharmaceutical News and Articles

Baxdrostat Demonstrated Statistically Significant and Clinically Meaningful Reduction in Systolic Blood Pressure in Patients with Hard-to-Control Hypertension in the BaxHTN Phase III Trial

Positive full results from the BaxHTN Phase III trial showed baxdrostat demonstrated a statistically significant and clinically meaningful reduction in mean sea

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

Greenwich LifeSciences, Inc. (Nasdaq GLSI) (the Company ), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, whic

U.S. FDA Approves Expanded Indication for Vonvendi [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease

FDA Approves Inlexzo (gemcitabine intravesical system) for the Treatment of Non-Muscle Invasive Bladder Cancer

FDA Approves Inlexzo (gemcitabine intravesical system) for the Treatment of Non-Muscle Invasive Bladder Cancer

FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer

FDA Approves Selumetinib for Pediatric Patients 1 year of Age and Older with Neurofibromatosis Type 1 with Symptomatic, Inoperable Plexiform Neurofibromas

The FDA expanded Koselugo’s approval to include children as young as 1 year with NF1 and symptomatic, inoperable plexiform neurofibromas.

FDA Approves Enbumyst (bumetanide) Nasal Spray for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease

FDA approves Enbumyst (bumetanide nasal spray) for treating edema in adults with congestive heart failure, liver disease, or renal disease including nephrotic syndrome.

Timing Of Menopause Hormone Therapy Key To Protecting Brain From Alzheimer's

WEDNESDAY, Sept. 17, 2025 Hormone replacement therapy might protect a woman s brain against Alzheimer s disease, but only if the timing s right, researchers say

FDA Cracks Down on Hims, Other Telehealth Companies Over Drug Ads

WEDNESDAY, Sept. 17, 2025 Federal health officials are cracking down on telehealth companies promotion of unapproved versions of prescription drugs, including p

DermaRite Widens Recall to 32 Products Over Bacteria Risk

WEDNESDAY, Sept. 17, 2025 DermaRite Industries has widened its earlier recall of hand soaps to include 32 personal care products that could be contaminated with